Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

Phase 1

2(25.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

Phase 2(4)

Phase 1(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05361733Phase 1Recruiting

A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.

Role: collaborator

NCT06872775Enrolling By Invitation

855303-RNA Biomarker Validation

Role: collaborator

NCT03538951Phase 2Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis

Role: collaborator

NCT03168581Phase 2Completed

A Proof of Concept Study to Evaluate CN-105 in ICH Patients

Role: collaborator

NCT03490396Phase 4Terminated

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

Role: collaborator

NCT03602118Phase 3Withdrawn

Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures

Role: lead

NCT03643874Phase 2Completed

Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma

Role: collaborator

NCT03373409Phase 1Completed

Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI

Role: collaborator

NCT02702778Phase 2Terminated

Delayed Release Prednisone in PMR

Role: collaborator

All 9 trials loaded